Artemis Medicare Receives Show Cause Notice for ₹11.11 Crore Tax Dispute
Artemis Medicare Services Limited received a Show Cause Notice from CGST, Gurugram, for ₹11.11 Crore related to the financial year 2022-23. The notice concerns alleged non-remittance of GST charged on medicines and consumables. The company plans to file a writ petition, connecting it to a previous case where a stay was granted.
The notice involves a significant financial claim of ₹11.11 Crore, plus interest and penalty. While the company plans to contest it, the potential financial and operational impact warrants a medium classification.
The company has received a Show Cause Notice regarding a tax dispute with potential financial implications of ₹11.11 Crore, which is a negative development.
Artemis Medicare Services Limited has received a Show Cause Notice dated September 28, 2026, from the Office of the Assistant Commissioner, CGST, Gurugram, concerning the financial year 2022-23. The notice alleges that the company charged Goods and Services Tax (GST) on medicines, consumables, and implants supplied to in-patients while providing healthcare services, but did not remit the same to the government.
The company has been informed that the expected financial implication, including potential interest and penalty, amounts to ₹11.11 Crore. Artemis Medicare Services Limited had previously filed a writ petition before the Hon’ble High Court of Punjab & Haryana, Chandigarh, regarding a similar Show Cause Notice for an earlier period. In that instance, the High Court granted an interim order staying further proceedings, which also applied to writ petitions filed by other hospitals.
Artemis Medicare is now in the process of filing another writ before the Hon’ble High Court of Punjab & Haryana, Chandigarh, to address this new Show Cause Notice and to link it with the previous pending writ. The company has affirmed that the information provided in Annexure A is true, correct, and complete to the best of their knowledge and belief.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.